NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Esperante

Esperante

Hoofddorpesperante.com

Overview

Esperante is a corporate venture capital firm that is part of a family-controlled global life science group, focusing on investments in mid to late-stage clinical therapeutics development companies in North America, Europe, and Israel.

Year Founded

2004

Portfolio Companies

9

Investments

Esperante investments
CompanyDateStageLead
Reconnect LabsAug 2025Series ACo-investor
Acousia Therapeutics GmbHJan 2024VC Round-
Spiral TherapeuticsAug 2023VC RoundLead
AMLo BiosciencesNov 2022VC RoundLead
AMLo BiosciencesApr 2022Series ACo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHoofddorp
Year Founded2004

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.